Skip to main content
. 2020 Jun 20;13:1756284820935189. doi: 10.1177/1756284820935189

Figure 2.

Figure 2.

PET scan performed in July 2018 (baseline) showing liver and lymph-node involvement. (b) PET scan performed in October 2018 following four injections of pembrolizumab showing partial response at the supra- and sub-diaphragmatic targets.

PET, positron emission tomography.